Evidence map›Paper›PMID 26469693›Full record

ReviewAnnals of the New York Academy of Sciences2015

Diseases caused by mutations in ORAI1 and STIM1.

Rodrigo S Lacruz, Stefan Feske

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 275 papers.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 438 citations in OpenAlex.

  1. Review
  2. Article
  3. Ryanodine Receptor 1 Is Dispensable for CD4European journal of immunology · 2026
    Article
  4. Evolutionarily conserved hydrophobicity and sterics in TM3/TM4 balance Orai1 pore opening.Protein science : a publication of the Protein Society · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. CRAC channels as targets for immunotherapy.Current opinion in immunology · 2026
    Review
  9. Review
  10. Review
  11. Mathematical Modeling of Calcium Dynamics in Ameloblasts.Calcified tissue international · 2026
    Article
  12. Review
  13. Review
  14. Mechanosensitive Piezo1 Channels in Enamel Cells.Calcified tissue international · 2026
    Article
  15. Article
  16. The scramblase anoctamin 9 controls the immune response in lymphocytes.Cellular and molecular life sciences : CMLS · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rodrigo S LacruzDepartment of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, New York.
Stefan FeskeDepartment of Pathology, New York University School of Medicine, New York, New York.
New York University · US

Funding

CRAC Channel Deficiency in Immunity to InfectionR01AI097302 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FESKE, STEFAN · 2012 to 2022
$5.6M
Calcium Regulation and Oral HealthR00DE022799 · NIDCR · NEW YORK UNIVERSITY · PI LACRUZ, RODRIGO S. · 2014 to 2016
$728k
CALCIUM REGULATION IN ORAL HEALTHK99DE022799 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LACRUZ, RODRIGO S. · 2012 to 2013
$214k
NIAID NIH HHS AI097302NIAID NIH HHS R01 AI097302NIDCR NIH HHS DE022799NIDCR NIH HHS K99 DE022799NIDCR NIH HHS R00 DE022799
6 · The paper itself

Abstract

Ca(2+) release-activated Ca(2+) (CRAC) channels mediate a specific form of Ca(2+) influx called store-operated Ca(2+) entry (SOCE) that contributes to the function of many cell types. CRAC channels are composed of ORAI1 proteins located in the plasma membrane, which form its ion-conducting pore. ORAI1 channels are activated by stromal interaction molecule (STIM) 1 and STIM2 located in the endoplasmic reticulum. Loss- and gain-of-function gene mutations in ORAI1 and STIM1 in human patients cause distinct disease syndromes. CRAC channelopathy is caused by loss-of-function mutations in ORAI1 and STIM1 that abolish CRAC channel function and SOCE; it is characterized by severe combined immunodeficiency (SCID)-like disease, autoimmunity, muscular hypotonia, and ectodermal dysplasia, with defects in sweat gland function and dental enamel formation. The latter defect emphasizes an important role of CRAC channels in tooth development. By contrast, autosomal dominant gain-of-function mutations in ORAI1 and STIM1 result in constitutive CRAC channel activation, SOCE, and increased intracellular Ca(2+) levels that are associated with an overlapping spectrum of diseases, including nonsyndromic tubular aggregate myopathy (TAM) and York platelet and Stormorken syndromes. The latter two syndromes are defined, besides myopathy, by thrombocytopenia, thrombopathy, and bleeding diathesis. The fact that myopathy results from both loss- and gain-of-function mutations in ORAI1 and STIM1 highlights the importance of CRAC channels for Ca(2+) homeostasis in skeletal muscle function. The cellular dysfunction and clinical disease spectrum observed in mutant patients provide important information about the molecular regulation of ORAI1 and STIM1 proteins and the role of CRAC channels in human physiology.

Indexed as

MutationAutoimmune DiseasesCalcium ChannelsChannelopathiesHumansMembrane ProteinsMuscle HypotoniaNeoplasm ProteinsORAI1 ProteinSevere Combined ImmunodeficiencyStromal Interaction Molecule 1Calcium ChannelsMembrane ProteinsNeoplasm ProteinsORAI1 ProteinORAI1 protein, humanSTIM1 protein, humanStromal Interaction Molecule 1ameloblastautoimmunityCa2+calciumchannelopathyCRAC channeldiseaseenamelmuscular hypotoniamutationORAI1plateletsskeletal muscleSOCESTIM1Stormorken syndromethrombocytopeniatubular aggregate myopathyYork platelet syndrome

Identifiers

PMID26469693
PMCPMC4692058
OpenAlexW1935830997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.